UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Determinants and Consequences of Adherence to the Dietary Approaches to Stop Hypertension Diet in African-American and White Adults with High Blood Pressure: Results from the ENCORE Trial

Journal of the Academy of Nutrition and Dietetics, 2012-11, Vol.112 (11), p.1763-1773

2012

Volltextzugriff (PDF)

Hormonal induction of adipogenesis induces Skp2 expression through PI3K and MAPK pathways

Journal of cellular biochemistry, 2007-01, Vol.100 (1), p.204-216

2007

Volltextzugriff (PDF)

The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature

Journal of clinical neuroscience, 2021-08, Vol.90, p.178-183

2021

Volltextzugriff (PDF)

Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs

Journal of medicinal chemistry, 2007-11, Vol.50 (23), p.5848-5852

2007

Volltextzugriff (PDF)

Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease

Neuropharmacology, 2020-05, Vol.167, p.108006, Article 108006

2020

Volltextzugriff (PDF)

Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia

The Journal of pharmacology and experimental therapeutics, 2018-02, Vol.364 (2), p.198-206

2018

Volltextzugriff (PDF)

Effects of safinamide on the glutamatergic striatal network in experimental Parkinson’s disease

Neuropharmacology, 2020-06, Vol.170, p.108024, Article 108024

2020

Volltextzugriff (PDF)

Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo

Experimental neurology, 2020-06, Vol.328, p.113287-113287, Article 113287

2020

Volltextzugriff (PDF)

Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor

Journal of medicinal chemistry, 2009-11, Vol.52 (21), p.6685-6706

2009

Volltextzugriff (PDF)

Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model

Neurotherapeutics, 2024-09, Vol.21 (6), p.e00455, Article e00455

2024

Volltextzugriff (PDF)

Safinamide and glutamate release: New insights

Parkinsonism & related disorders, 2016-01, Vol.22, p.e177-e177

2016

Volltextzugriff (PDF)

Safinamide differentially modulates glutamate release in the basal ganglia nuclei

Parkinsonism & related disorders, 2016-01, Vol.22, p.e176-e177

2016

Volltextzugriff (PDF)

Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study

Archives of internal medicine (1960), 2010-01, Vol.170 (2), p.126

2010

Volltextzugriff (PDF)

Solid-Phase Synthesis and Insights into Structure−Activity Relationships of Safinamide Analogues as Potent and Selective Inhibitors of Type B Monoamine Oxidase

Journal of medicinal chemistry, 2007-10, Vol.50 (20), p.4909-4916

2007

Volltextzugriff (PDF)

Weight loss intervention for young adults using mobile technology: Design and rationale of a randomized controlled trial — Cell Phone Intervention for You (CITY)

Contemporary clinical trials, 2014-03, Vol.37 (2), p.333-341

2014

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity

Pharmacological research, 2004-07, Vol.50 (1), p.77-85

2004

Volltextzugriff (PDF)

Determinants and Consequences of Adherence to the DASH Diet in African American and White Adults with High Blood Pressure: Results from the ENCORE Trial

Journal of the Academy of Nutrition and Dietetics, 2012-09, Vol.112 (11), p.1763-1773

2012

Volltextzugriff (PDF)

Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2 H -chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor

Journal of medicinal chemistry, 2009-11, Vol.52 (21), p.6685-6706

2009

Volltextzugriff (PDF)

Corrigendum to “Weight loss intervention for young adults using mobile technology: Design and rationale of a randomized controlled trial — Cell phone Intervention for You (CITY)” [Contemp Clin Trials 37/2 (2014) 333–341]

Contemporary clinical trials, 2014-11, Vol.39 (2), p.351-351

2014

Volltextzugriff (PDF)

Regulation of Skp2 promoter activity by PI3K and NFkB during preadipocyte proliferation

The FASEB journal, 2006-03, Vol.20 (4), p.A164-A164

2006

Volltextzugriff (PDF)

Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-(methylamino)methyl]-2H chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor

Journal of medicinal chemistry, 2009, Vol.52 (21), p.6685-6706

2009

Volltextzugriff (PDF)

5(10→9)Abeo-ergoline derivatives : Synthesis, 5-HT1A-receptor affinity and selectivity

European journal of medicinal chemistry, 1998-04, Vol.33 (4), p.279-292

1998

Volltextzugriff (PDF)

Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition

Clinical neuropharmacology, 2003-07, Vol.26 (4), p.213-217

2003

Volltextzugriff (PDF)

Phenylimidazolidin-2-one Derivatives as Selective 5-HT3 Receptor Antagonists and Refinement of the Pharmacophore Model for 5-HT3 Receptor Binding

Journal of medicinal chemistry, 1997-10, Vol.40 (21), p.3369-3380

1997

Volltextzugriff (PDF)

Sodium channel activity and sigma binding of 2-aminopropanamide anticonvulsants

Bioorganic & medicinal chemistry letters, 1999-09, Vol.9 (17), p.2521-2524

1999

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(57)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Pharmacology & Pharmacy
(18)
Pharmacology. Drug Treatments
(15)
Animals
(14)
Neuropharmacology
(13)
Rats
(13)
Humans
(11)
Male
(11)
Chemistry, Medicinal
(10)
Neurotransmitters. Neurotransmission. Receptors
(8)
Alanine - Analogs & Derivatives
(7)
Alanine - Pharmacology
(6)
Benzylamines - Pharmacology
(6)
Chemistry
(6)
Physical Sciences
(6)
Safinamide
(6)
Structure-Activity Relationship
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Determinants and Consequences of Adherence to the Dietary Approaches to Stop Hypertension Diet in African-American and White Adults with High Blood Pressure: Results from the ENCORE Trial

Hormonal induction of adipogenesis induces Skp2 expression through PI3K and MAPK pathways

The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature

Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs

Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease

Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia

Effects of safinamide on the glutamatergic striatal network in experimental Parkinson’s disease

Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo

Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model

Safinamide and glutamate release: New insights

Safinamide differentially modulates glutamate release in the basal ganglia nuclei

Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study

Solid-Phase Synthesis and Insights into Structure−Activity Relationships of Safinamide Analogues as Potent and Selective Inhibitors of Type B Monoamine Oxidase

Weight loss intervention for young adults using mobile technology: Design and rationale of a randomized controlled trial — Cell Phone Intervention for You (CITY)

Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity

Determinants and Consequences of Adherence to the DASH Diet in African American and White Adults with High Blood Pressure: Results from the ENCORE Trial

Corrigendum to “Weight loss intervention for young adults using mobile technology: Design and rationale of a randomized controlled trial — Cell phone Intervention for You (CITY)” [Contemp Clin Trials 37/2 (2014) 333–341]

Regulation of Skp2 promoter activity by PI3K and NFkB during preadipocyte proliferation

5(10→9)Abeo-ergoline derivatives : Synthesis, 5-HT1A-receptor affinity and selectivity

Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition

Phenylimidazolidin-2-one Derivatives as Selective 5-HT3 Receptor Antagonists and Refinement of the Pharmacophore Model for 5-HT3 Receptor Binding

Sodium channel activity and sigma binding of 2-aminopropanamide anticonvulsants

Suchergebnisse filtern